Drug details

H.P. Acthar Gel (repository corticotropin injection)

type of

H.P. Acthar (repository corticotropin) Gel is an adrenocorticotropic hormone used to treat relapsing multiple sclerosis (MS), infantile spasms, and nephrotic syndrome (a collection of symptoms that indicate kidney damage). H.P. Acthar Gel is also used to treat dermatomyositis (a chronic inflammatory disease of skin and muscle associated with patches of raised reddish or scaly rash) and polymyositis (an autoimmune inflammatory disease of muscle).

This drug may have the following side effects:
  • headache,
  • dizziness,
  • infections,
  • increased sweating,
  • trouble sleeping,
  • acne,
  • dry skin,
  • spinning sensation,
  • thinning skin,
  • bruising or discoloration,
  • slow wound healing,
  • upset stomach, or
  • stomach ulcers, and
  • changes in mood and behavior such as irritability or depression,
The following drugs are related to H.P. Acthar Gel, either as a replacement or used together:
  • Avonex (interferon beta-1a)
  • Betaseron (interferon beta-1b)
  • Wynzora (calcipotriene and betamethasone dipropionate cream)
  • Oxervate (cenegermin-bkbj ophthalmic solution)
  • Copaxone (glatiramer acetate)
  • Dantrium Capsules (dantrolene sodium capsules)
  • Dantrium IV (dantrolene sodium for injection)
  • Gilenya (fingolimod capsules)
  • Rebif (interferon beta-1a)
  • Novantrone (mitoxantrone for injection concentrate)
  • Tysabri (natalizumab)
  • Zeposia (ozanimod capsules)
  • Sezaby (phenobarbital sodium for injection)